{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:40:28Z","timestamp":1790883628784,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China grants","doi-asserted-by":"crossref","award":["32060180"],"award-info":[{"award-number":["32060180"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China grants","doi-asserted-by":"crossref","award":["81860644"],"award-info":[{"award-number":["81860644"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China grants","doi-asserted-by":"crossref","award":["81560596"],"award-info":[{"award-number":["81560596"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China grants","doi-asserted-by":"crossref","award":["31560051"],"award-info":[{"award-number":["31560051"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005273","name":"Natural Science Foundation of Yunnan Province","doi-asserted-by":"publisher","award":["2017FE467-(001)"],"award-info":[{"award-number":["2017FE467-(001)"]}],"id":[{"id":"10.13039\/501100005273","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005273","name":"Natural Science Foundation of Yunnan Province","doi-asserted-by":"publisher","award":["2019FE001-(002)"],"award-info":[{"award-number":["2019FE001-(002)"]}],"id":[{"id":"10.13039\/501100005273","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Leptospirosis, an important zoonotic bacterial disease, commonly affects resource-poor populations and results in significant morbidity and mortality worldwide. The value of antibiotics in leptospirosis remains unclear, as evidenced by the conflicting opinions published.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a search in the PubMed, Web of Science, and Cochrane Library databases for studies. These studies included clinical trials and retrospective studies that evaluated the efficacy or safety of antibiotics for leptospirosis treatment. The primary outcomes assessed were defervescence time, mortality rate, and hospital stays. Subgroup analyses were performed based on whether there were cases involving children and whether there were cases of severe jaundice. Safety was defined as the prevalence of adverse events associated with the use of antibiotics.\n                      <jats:italic>p<\/jats:italic>\n                      scores were utilized to rank the efficacy of the antibiotics.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There are included 9 randomized controlled trials (RCTs), 1 control trial (CT), and 3 retrospective studies (RS) involving 920 patients and 8 antibiotics. Six antibiotics resulted in significantly shorter defervescence times compared to the control, namely cefotaxime (MD,\u2009\u2212\u20091.88; 95% CI\u2009=\u2009\u2009\u2212\u20092.60 to\u2009\u2212\u20091.15), azithromycin (MD,\u2009\u2212\u20091.74; 95% CI\u2009=\u2009\u2009\u2212\u20092.52 to\u2009\u2212\u20090.95), doxycycline (MD,\u2009\u2212\u20091.53; 95% CI\u2009=\u2009\u2009\u2212\u20092.05 to\u2009\u2212\u20091.00), ceftriaxone (MD,\u2009\u2212\u20091.22; 95% CI\u2009=\u2009\u2009\u2212\u20091.89 to\u2009\u2212\u20090.55), penicillin (MD,\u2009\u2212\u20091.22; 95% CI\u2009=\u2009\u2009\u2212\u20091.80 to\u2009\u2212\u20090.64), and penicillin or ampicillin (MD,\u2009\u2212\u20090.08; 95% CI\u2009=\u2009\u2009\u2212\u20091.01 to\u2009\u2212\u20090.59). The antibiotics were not effective in reducing the mortality and hospital stays. Common adverse reactions to antibiotics included Jarisch\u2013Herxheimer reaction, rash, headache, and digestive reactions (nausea, vomiting, diarrhea, abdominal pain, and others).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Findings recommend that leptospirosis patients be treated with antibiotics, which significantly reduced the leptospirosis defervescence time. Cephalosporins, doxycycline, and penicillin are suggested, and azithromycin may be a suitable alternative for drug-resistant cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>PROSPERO CRD42022354938.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13643-024-02519-y","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T09:46:43Z","timestamp":1713260803000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Efficacy and safety of antibiotics for treatment of leptospirosis: a systematic review and network meta-analysis"],"prefix":"10.1186","volume":"13","author":[{"given":"Zhenhua","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaru","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieqin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinya","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2652-6660","authenticated-orcid":false,"given":"Fukai","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,16]]},"reference":[{"key":"2519_CR1","doi-asserted-by":"publisher","first-page":"106438","DOI":"10.1016\/j.mimet.2022.106438","volume":"195","author":"GV Pinto","year":"2022","unstructured":"Pinto GV, Senthilkumar K, Rai P, Kabekkodu SP, Karunasagar I, Kumar BK. Current methods for the diagnosis of leptospirosis: issues and challenges. J Microbiol Methods. 2022;195:106438.","journal-title":"J Microbiol Methods"},{"key":"2519_CR2","doi-asserted-by":"publisher","first-page":"e0003898","DOI":"10.1371\/journal.pntd.0003898","volume":"9","author":"F Costa","year":"2015","unstructured":"Costa F, Hagan JE, Calcagno J, Kane M, Torgerson P, Martinez-Silveira MS, et al. Global morbidity and mortality of leptospirosis: a systematic review. PLoS Negl Trop Dis. 2015;9:e0003898.","journal-title":"PLoS Negl Trop Dis"},{"key":"2519_CR3","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.2217\/fmb.10.102","volume":"5","author":"KV Evangelista","year":"2010","unstructured":"Evangelista KV, Coburn J. Leptospira as an emerging pathogen: a review of its biology, pathogenesis and host immune responses. Future Microbiol. 2010;5:1413\u201325.","journal-title":"Future Microbiol"},{"key":"2519_CR4","doi-asserted-by":"publisher","first-page":"105183","DOI":"10.1016\/j.actatropica.2019.105183","volume":"201","author":"ZMP Soo","year":"2020","unstructured":"Soo ZMP, Khan NA, Siddiqui R. Leptospirosis: increasing importance in developing countries. Acta Trop. 2020;201:105183.","journal-title":"Acta Trop"},{"key":"2519_CR5","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S1473-3099(03)00830-2","volume":"3","author":"AR Bharti","year":"2003","unstructured":"Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis. 2003;3:757\u201371.","journal-title":"Lancet Infect Dis"},{"key":"2519_CR6","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s11102-021-01156-1","volume":"24","author":"J Gohil","year":"2021","unstructured":"Gohil J, Gowda A, George T, Easwer HV, George A, Nair P. Pituitary apoplexy and panhypopituitarism following acute leptospirosis. Pituitary. 2021;24:854\u20138.","journal-title":"Pituitary"},{"key":"2519_CR7","first-page":"245","volume":"6","author":"HL Eric Klaasen","year":"2015","unstructured":"Eric Klaasen HL, Adler B. Recent advances in canine leptospirosis: focus on vaccine development. Vet Med (Auckl). 2015;6:245\u201360.","journal-title":"Vet Med (Auckl)"},{"key":"2519_CR8","doi-asserted-by":"publisher","first-page":"296e326","DOI":"10.1128\/CMR.14.2.296-326.2001","volume":"14","author":"PN Levett","year":"2001","unstructured":"Levett PN. Leptospirosis. Clin Microbiol Rev. 2001;14:296e326.","journal-title":"Clin Microbiol Rev"},{"key":"2519_CR9","doi-asserted-by":"publisher","first-page":"e230619","DOI":"10.1136\/bcr-2019-230619","volume":"12","author":"ID Tomacruz","year":"2019","unstructured":"Tomacruz ID, Sandejas JC, Berba R, Sacdalan DR. Behavioural change: a rare presentation of leptospirosis. BMJ Case Rep. 2019;12:e230619.","journal-title":"BMJ Case Rep"},{"key":"2519_CR10","doi-asserted-by":"publisher","first-page":"101532","DOI":"10.1016\/j.cimid.2020.101532","volume":"73","author":"BR Rocha","year":"2020","unstructured":"Rocha BR, Martins G, Lilenbaum W. An historical view of the experimental leptospiral infection in ruminants. Comp Immunol Microbiol Infect Dis. 2020;73:101532.","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"2519_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.7861\/clinmed.2021-0784","volume":"22","author":"S Rajapakse","year":"2022","unstructured":"Rajapakse S. Leptospirosis: clinical aspects. Clin Med (Lond). 2022;22:14\u20137.","journal-title":"Clin Med (Lond)"},{"key":"2519_CR12","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1001\/jama.2019.0697","volume":"321","author":"D Grennan","year":"2019","unstructured":"Grennan D. Leptospirosis. JAMA. 2019;321:812.","journal-title":"JAMA"},{"key":"2519_CR13","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3390\/pathogens10091125","volume":"10","author":"M Guzm\u00e1n P\u00e9rez","year":"2021","unstructured":"Guzm\u00e1n P\u00e9rez M, Blanch Sancho JJ, Segura Luque JC, Mateos Rodriguez F, Mart\u00ednez Alfaro E, Sol\u00eds Garc\u00eda Del Pozo J. Current evidence on the antimicrobial treatment and chemoprophylaxis of human leptospirosis: a meta-analysis. Pathogens. 2021;10:1125.","journal-title":"Pathogens"},{"key":"2519_CR14","first-page":"CD008264","volume":"2","author":"DM Brett-Major","year":"2012","unstructured":"Brett-Major DM, Coldren R. Antibiotics for leptospirosis. Cochrane Database Syst Rev. 2012;2:CD008264.","journal-title":"Cochrane Database Syst Rev"},{"key":"2519_CR15","first-page":"CD001306","volume":"2","author":"F Guidugli","year":"2000","unstructured":"Guidugli F, Castro AA, Atallah AN. Antibiotics for treating leptospirosis. Cochrane Database Syst Rev. 2000;2:CD001306.","journal-title":"Cochrane Database Syst Rev"},{"key":"2519_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12879-016-2145-3","volume":"17","author":"C Naing","year":"2017","unstructured":"Naing C, Reid SA, Aung K. Comparing antibiotic treatment for leptospirosis using network meta-analysis: a tutorial. BMC Infect Dis. 2017;17:29.","journal-title":"BMC Infect Dis"},{"key":"2519_CR17","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"2519_CR18","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"key":"2519_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2288-5-13","volume":"5","author":"SP Hozo","year":"2005","unstructured":"Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.","journal-title":"BMC Med Res Methodol"},{"key":"2519_CR20","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1177\/09622802211047348","volume":"30","author":"S Cai","year":"2021","unstructured":"Cai S, Zhou J, Pan J. Estimating the sample mean and standard deviation from order statistics and sample size in meta-analysis. Stat Methods Med Res. 2021;30:2701\u201319.","journal-title":"Stat Methods Med Res"},{"key":"2519_CR21","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/sim.3767","volume":"29","author":"S Dias","year":"2010","unstructured":"Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010;29:932\u201344.","journal-title":"Stat Med"},{"key":"2519_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12874-015-0060-8","volume":"15","author":"G R\u00fccker","year":"2015","unstructured":"R\u00fccker G, Schwarzer G. Ranking treatments in frequentist network meta-analysis works without resampling methods. BMC Med Res Methodol. 2015;15:1\u20139.","journal-title":"BMC Med Res Methodol"},{"key":"2519_CR23","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.3389\/fimmu.2019.02089","volume":"10","author":"Z Ji","year":"2019","unstructured":"Ji Z, Jian M, Chen T, Luo L, Li L, Dai X, et al. Immunogenicity and safety of the M72\/AS01E candidate vaccine against tuberculosis: a meta-analysis. Front Immunol. 2019;10:2089.","journal-title":"Front Immunol"},{"key":"2519_CR24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3390\/pathogens11020143","volume":"11","author":"Z Ji","year":"2022","unstructured":"Ji Z, Jian M, Yue P, Cao W, Xu X, Zhang Y, et al. Prevalence of Borrelia burgdorferi in Ixodidae tick around Asia: a systematic review and meta-analysis. Pathogens. 2022;11:143.","journal-title":"Pathogens"},{"key":"2519_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/imj.1955.4.1.53","volume":"4","author":"RL Doherty","year":"1955","unstructured":"Doherty RL. A clinical study of leptospirosis in North Queensland. Australas Ann Med. 1955;4:53\u201363.","journal-title":"Australas Ann Med"},{"key":"2519_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0140-6736(56)91853-0","volume":"270","author":"AC Fairburn","year":"1956","unstructured":"Fairburn AC, Semple SJ. Chloramphenicol and penicillin in the treatment of leptospirosis among British troops in Malaya. Lancet. 1956;270:13\u20136.","journal-title":"Lancet"},{"key":"2519_CR27","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/S0140-6736(58)92405-X","volume":"2","author":"RW Russell","year":"1958","unstructured":"Russell RW. Treatment of leptospirosis with oxytetracycline. Lancet. 1958;2:1143\u20135.","journal-title":"Lancet"},{"key":"2519_CR28","doi-asserted-by":"publisher","first-page":"696","DOI":"10.7326\/0003-4819-100-5-696","volume":"100","author":"JB McClain","year":"1984","unstructured":"McClain JB, Ballou WR, Harrison SM, Steinweg DL. Doxycycline therapy for leptospirosis. Ann Intern Med. 1984;100:696\u20138.","journal-title":"Ann Intern Med"},{"key":"2519_CR29","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0140-6736(88)91230-5","volume":"1","author":"G Watt","year":"1988","unstructured":"Watt G, Padre LP, Tuazon ML, Calubaquib C, Santiago E, Ranoa CP, et al. Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis. Lancet. 1988;1:433\u20135.","journal-title":"Lancet"},{"key":"2519_CR30","doi-asserted-by":"publisher","first-page":"388","DOI":"10.4269\/ajtmh.1988.39.388","volume":"39","author":"CN Edwards","year":"1988","unstructured":"Edwards CN, Nicholson GD, Hassell TA, Everard CO, Callender J. Penicillin therapy in icteric leptospirosis. Am J Trop Med Hyg. 1988;39:388\u201390.","journal-title":"Am J Trop Med Hyg"},{"key":"2519_CR31","doi-asserted-by":"publisher","first-page":"307","DOI":"10.4269\/ajtmh.1997.56.307","volume":"56","author":"PC Marotto","year":"1997","unstructured":"Marotto PC, Marotto MS, Santos DL, Souza TN, Seguro AC. Outcome of leptospirosis in children. Am J Trop Med Hyg. 1997;56:307\u201310.","journal-title":"Am J Trop Med Hyg"},{"key":"2519_CR32","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1590\/S0036-46652000000600005","volume":"42","author":"EF Daher","year":"2000","unstructured":"Daher EF, Nogueira CB. Evaluation of penicillin therapy in patients with leptospirosis and acute renal failure. Rev Inst Med Trop Sao Paulo. 2000;42:327\u201332.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"2519_CR33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1590\/S0036-46652003000300005","volume":"45","author":"E Costa","year":"2003","unstructured":"Costa E, Lopes AA, Sacramento E, Costa YA, Matos ED, Lopes MB, et al. Penicillin at the late stage of leptospirosis: a randomized controlled trial. Rev Inst Med Trop Sao Paulo. 2003;45:141\u20135.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"2519_CR34","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1086\/375226","volume":"36","author":"T Panaphut","year":"2003","unstructured":"Panaphut T, Domrongkitchaiporn S, Vibhagool A, Thinkamrop B. Ceftriaxone compared with sodium penicillin G for treatment of severe leptospirosis. Clin Infect Dis. 2003;36:1507\u201313.","journal-title":"Clin Infect Dis"},{"key":"2519_CR35","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1086\/425001","volume":"39","author":"Y Suputtamongkol","year":"2004","unstructured":"Suputtamongkol Y, Niwattayakul K, Suttinont C, Losuwanaluk K, Limpaiboon R, Chierakul W, et al. An open, randomized, controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis. Clin Infect Dis. 2004;39:1417\u201324.","journal-title":"Clin Infect Dis"},{"key":"2519_CR36","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1128\/AAC.00508-07","volume":"51","author":"K Phimda","year":"2007","unstructured":"Phimda K, Hoontrakul S, Suttinont C, Chareonwat S, Losuwanaluk K, Chueasuwanchai S, et al. Doxycycline versus azithromycin for treatment of leptospirosis and scrub typhus. Antimicrob Agents Chemother. 2007;51:3259\u201363.","journal-title":"Antimicrob Agents Chemother"},{"key":"2519_CR37","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/j.1365-2710.2011.01312.x","volume":"37","author":"EF Daher","year":"2012","unstructured":"Daher EF, Silva GB Jr, de Abreu KL, Mota RM, Batista DV, Rocha NA, et al. Leptospirosis-associated acute kidney injury: penicillin at the late stage is still controversial. J Clin Pharm Ther. 2012;37:420\u20135.","journal-title":"J Clin Pharm Ther"},{"key":"2519_CR38","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ijantimicag.2006.08.021","volume":"28","author":"G Pappas","year":"2006","unstructured":"Pappas G, Cascio A. Optimal treatment of leptospirosis: queries and projections. Int J Antimicrob Agents. 2006;28:491\u20136.","journal-title":"Int J Antimicrob Agents"},{"key":"2519_CR39","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1086\/375275","volume":"36","author":"JM Vinetz","year":"2003","unstructured":"Vinetz JM. A mountain out of a molehill: do we treat acute leptospirosis, and if so, with what? Clin Infect Dis. 2003;36:1514\u20135.","journal-title":"Clin Infect Dis"},{"key":"2519_CR40","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0924-8579(99)00134-X","volume":"13","author":"SC Sehgal","year":"2000","unstructured":"Sehgal SC, Sugunan AP, Murhekar MV, Sharma S, Vijayachari P. Randomized controlled trial of doxycycline prophylaxis against leptospirosis in an endemic area. Int J Antimicrob Agents. 2000;13:249\u201355.","journal-title":"Int J Antimicrob Agents"},{"key":"2519_CR41","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJM198402233100805","volume":"310","author":"ET Takafuji","year":"1984","unstructured":"Takafuji ET, Kirkpatrick JW, Miller RN, Karwacki JJ, Kelley PW, Gray MR, et al. An efficacy trial of doxycycline chemoprophylaxis against leptospirosis. N Engl J Med. 1984;310:497\u2013500.","journal-title":"N Engl J Med"},{"key":"2519_CR42","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1093\/trstmh\/tru148","volume":"108","author":"C Rodrigo","year":"2014","unstructured":"Rodrigo C, de LakshithaSilva N, Goonaratne R, Samarasekara K, Wijesinghe I, Parththipan B, et al. High dose corticosteroids in severe leptospirosis: a systematic review. Trans R Soc Trop Med Hyg. 2014;108:743\u201350.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2519_CR43","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fcimb.2018.00204","volume":"8","author":"J Cagliero","year":"2018","unstructured":"Cagliero J, Villanueva SYAM, Matsui M. Leptospirosis pathophysiology: into the storm of cytokines. Front Cell Infect Microbiol. 2018;8:204.","journal-title":"Front Cell Infect Microbiol"},{"key":"2519_CR44","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1517\/14656566.5.4.819","volume":"5","author":"JF Faucher","year":"2004","unstructured":"Faucher JF, Hoen B, Estavoyer JM. The management of leptospirosis. Expert Opin Pharmacother. 2004;5:819\u201327.","journal-title":"Expert Opin Pharmacother"},{"key":"2519_CR45","first-page":"109","volume":"30","author":"CW Yang","year":"2007","unstructured":"Yang CW. Leptospirosis in Taiwan\u2013an underestimated infectious disease. Chang Gung Med J. 2007;30:109\u201315.","journal-title":"Chang Gung Med J"},{"key":"2519_CR46","first-page":"400","volume":"32","author":"F Daher Ede","year":"2010","unstructured":"Daher Ede F, de Abreu KL, da Silva Junior GB. Leptospirosis-associated acute kidney injury. J Bras Nefrol. 2010;32:400\u20137.","journal-title":"J Bras Nefrol"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-024-02519-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-024-02519-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-024-02519-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T09:51:04Z","timestamp":1713261064000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-024-02519-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,16]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2519"],"URL":"https:\/\/doi.org\/10.1186\/s13643-024-02519-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3599824\/v1","asserted-by":"object"}]},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,16]]},"assertion":[{"value":"13 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work does not involve any participants and as such ethical approval was not sought.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"108"}}